Published in Eur J Neurol on March 01, 2005
Reforming research ethics committees. BMJ (2005) 1.56
Is your ethics committee efficient? Using "IRB Metrics" as a self-assessment tool for continuous improvement at the Faculty of Tropical Medicine, Mahidol University, Thailand. PLoS One (2014) 1.16
An eight-year follow-up national study of medical school and general hospital ethics committees in Japan. BMC Med Ethics (2007) 1.02
A five year follow-up national study of ethics committees in medical organizations in Japan. HEC Forum (2008) 0.78
Informed consent: time for more transparency. Arthritis Res Ther (2010) 0.75
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging (2009) 5.98
ESPEN guidelines for nutrition screening 2002. Clin Nutr (2003) 5.22
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage (2002) 3.88
Description of 1,108 older patients referred by their physician to the "Geriatric Frailty Clinic (G.F.C) for Assessment of Frailty and Prevention of Disability" at the gerontopole. J Nutr Health Aging (2014) 3.37
The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition (1999) 3.28
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology (2001) 2.78
Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev (1996) 2.58
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging (2008) 2.54
The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging (2008) 2.53
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry (2006) 2.48
Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging (2013) 2.44
Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci (2001) 2.43
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 2.12
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism (1997) 1.97
Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry (2009) 1.86
Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging (2009) 1.85
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology (2012) 1.78
Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil. Curr Med Res Opin (2002) 1.78
Report of the task force on designing clinical trials in early (predementia) AD. Neurology (2010) 1.75
The primary care physician and Alzheimer's disease: an international position paper. J Nutr Health Aging (2010) 1.68
Economic evaluation of donepezil in moderate to severe Alzheimer disease. Neurology (2004) 1.65
Protein-energy oral supplementation in malnourished nursing-home residents. A controlled trial. Age Ageing (2000) 1.63
Psychosocial work factors and dementia. Occup Environ Med (2004) 1.62
Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting. J Nutr Health Aging (2013) 1.57
A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects. Age Ageing (1994) 1.56
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry (2008) 1.54
Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs. J Intern Med (2013) 1.52
Instrumental activities of daily living as a potential marker of frailty: a study of 7364 community-dwelling elderly women (the EPIDOS study). J Gerontol A Biol Sci Med Sci (2001) 1.47
IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease. Neurology (2007) 1.45
IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging (2007) 1.44
Minimum data set for nutritional intervention studies in the elderly IAG/ IANA task force consensus. J Nutr Health Aging (2004) 1.40
Health and nutritional promotion program for patients with dementia (NutriAlz Study): design and baseline data. J Nutr Health Aging (2009) 1.40
[Mild cognitive impairment with predictors of rapid decline]. Dtsch Med Wochenschr (2008) 1.39
The Mini Nutritional Assessment (MNA) for grading the nutritional state of elderly patients: presentation of the MNA, history and validation. Nestle Nutr Workshop Ser Clin Perform Programme (1999) 1.36
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry (2013) 1.30
Prospective study of restriction of activity in old people after falls. Age Ageing (1987) 1.28
IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. J Nutr Health Aging (2007) 1.28
Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol Psychiatry (2010) 1.24
Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res (1998) 1.21
Effects of arousing emotional scenes on the distribution of visuospatial attention: changes with aging and early subcortical vascular dementia. J Neurol Sci (2004) 1.19
Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment. Eur J Nucl Med Mol Imaging (2012) 1.19
Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging (2010) 1.17
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing. Exp Neurol (2009) 1.17
Realistic expectations for treatment success in Alzheimer's disease. J Nutr Health Aging (2006) 1.15
Management of osteoporosis in the elderly. Curr Med Res Opin (2009) 1.14
Relationships between nutritional markers and the mini-nutritional assessment in 155 older persons. J Am Geriatr Soc (2000) 1.13
Alzheimer disease: protective factors. Am J Clin Nutr (2000) 1.13
Functional imaging of visuospatial processing in Alzheimer's disease. Neuroimage (2002) 1.11
Implementing frailty into clinical practice: we cannot wait. J Nutr Health Aging (2012) 1.11
The New Mexico aging process study (1979-2003). A longitudinal study of nutrition, health and aging. J Nutr Health Aging (2007) 1.10
Aging society and gerontechnology: a solution for an independent living? J Nutr Health Aging (2014) 1.09
Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement Geriatr Cogn Disord (2012) 1.09
Malnutrition and falls. Lancet (1990) 1.08
Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. Neurosci Lett (1999) 1.08
Apathy and cortical atrophy in Alzheimer's disease. Int J Geriatr Psychiatry (2010) 1.07
Weight loss in Alzheimer disease. Am J Clin Nutr (2000) 1.07
The integration of frailty into clinical practice: preliminary results from the Gérontopôle. J Nutr Health Aging (2012) 1.06
A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. Neurology (2009) 1.05
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment. J Nutr Health Aging (2009) 1.04
Influence of age on rectal tone and sensitivity to distension in healthy subjects. Neurogastroenterol Motil (1999) 1.03
Nutrition assessment in the elderly. Curr Opin Clin Nutr Metab Care (2001) 1.00
Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study. J Nutr Health Aging (2010) 1.00
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology (2008) 1.00
Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology (2009) 0.98
Differential validity of psychometric tests in dementia of the Alzheimer type. Psychiatry Res (1992) 0.98
Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease. Curr Med Res Opin (2002) 0.98
Cholesterol reduction and increased cardiovascular fitness following a 12 weeks brisk walking. J Nutr Health Aging (2002) 0.97
The ICTUS Study: A Prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology (2007) 0.95
Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial). J Nutr Health Aging (2012) 0.95
Sarcopenia: designing phase IIB trials. J Nutr Health Aging (2011) 0.94
Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials? J Nutr Health Aging (2007) 0.94
Dementia of the Alzheimer type: effects on the spontaneous EEG described by dipole sources. Psychiatry Res (1993) 0.94
Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem (1995) 0.94
A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's disease. J Nutr Health Aging (2001) 0.94
[The effect of psychosocial factors on risk of dementia]. Fortschr Neurol Psychiatr (2002) 0.93
Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Alzheimers Dement (2009) 0.93
Longitudinal changes in serum 25-hydroxyvitamin D in older people. Metabolism (1999) 0.93
Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Société Française de Gériatrie et de Gérontologie) Workshop--Athens January 20-21, 2012. J Nutr Health Aging (2013) 0.92
How should we deal with missing data in clinical trials involving Alzheimer's disease patients? Curr Alzheimer Res (2011) 0.92
Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer's disease consortium (EADC) study. Acta Clin Belg (2008) 0.92
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study. J Neurol Neurosurg Psychiatry (2009) 0.92
Predictive factors of emergency hospitalisation in Alzheimer's patients: results of one-year follow-up in the REAL.FR Cohort. J Nutr Health Aging (2005) 0.91
Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research). J Nutr Health Aging (2011) 0.91
Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging (2008) 0.91
Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry (1998) 0.91
[Falls, frailty and osteoporosis in the elderly: a public health problem]. Rev Med Interne (2000) 0.91
Passive immunotherapy for Alzheimer's disease: what have we learned, and where are we headed? J Nutr Health Aging (2013) 0.91
Carla Task Force on Sarcopenia: propositions for clinical trials. J Nutr Health Aging (2009) 0.90
Clinical practice patterns of generalists and specialists in Alzheimer's disease: what are the differences, and what difference do they make? J Nutr Health Aging (2010) 0.90
Event-related potentials and psychopharmacology. Cholinergic modulation of P300. Pharmacopsychiatry (1994) 0.90
Multimodal imaging of residual function and compensatory resource allocation in cortical atrophy: a case study of parietal lobe function in a patient with Huntington's disease. Psychiatry Res (1999) 0.90
[Burden experienced by informal caregivers assisting Alzheimer's patients in the REAL.FR study]. Rev Med Interne (2003) 0.90
An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment. J Intern Med (2013) 0.90
Living alone with Alzheimer's disease: cross-sectional and longitudinal analysis in the REAL.FR Study. J Nutr Health Aging (2005) 0.90
["The 5 words": a simple and sensitive test for the diagnosis of Alzheimer's disease]. Presse Med (2002) 0.89
Cerebral amyloid angiopathy and microhemorrhages after amyloid beta vaccination: case report and brief review. Clin Neuropathol (2010) 0.89
Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: the REAL longitudinal cohort study. Int J Geriatr Psychiatry (2009) 0.89
Consensus statement on dementia education and training in Europe. J Nutr Health Aging (2010) 0.89
Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: relation to severity of dementia. Psychiatry Res (1991) 0.88